EPZM logo

Epizyme (EPZM) Long Term Liabilities

EPZM Annual Total Long Term Liabilities

$264.49 M
+$19.22 M+7.83%

31 December 2021

EPZM Long Term Liabilities Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

EPZM Quarterly Long Term Liabilities

$249.49 M
-$12.61 M-4.81%

30 June 2022

EPZM Quarterly Long Term Liabilities Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

EPZM Long Term Liabilities Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+7.8%+2.2%
3 y3 years+5577.0%+2015.4%
5 y5 years+802.0%+757.6%

EPZM Long Term Liabilities High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year
5 y5-year
alltimeall timeat high-8.3%

Epizyme Long Term Liabilities History

DateAnnualQuarterly
June 2022
-
$249.49 M(-4.8%)
Mar 2022
-
$262.10 M(-0.9%)
Dec 2021
$264.49 M(+7.8%)
$264.49 M(-2.8%)
Sept 2021
-
$272.16 M(+11.5%)
June 2021
-
$244.03 M(-0.3%)
Mar 2021
-
$244.67 M(-0.2%)
Dec 2020
$245.28 M(+315.3%)
$245.28 M(+139.1%)
Sept 2020
-
$102.57 M(-0.8%)
June 2020
-
$103.36 M(+22.9%)
Mar 2020
-
$84.14 M(+42.4%)
Dec 2019
$59.07 M(+1167.8%)
$59.07 M(+435.6%)
Sept 2019
-
$11.03 M(-6.5%)
June 2019
-
$11.79 M(-6.0%)
Mar 2019
-
$12.54 M(+169.2%)
Dec 2018
$4.66 M(-84.1%)
$4.66 M(+1.9%)
Sept 2018
-
$4.57 M(+0.1%)
June 2018
-
$4.57 M(+3.0%)
Mar 2018
-
$4.44 M(-84.9%)
Dec 2017
$29.32 M
$29.32 M(+0.5%)
Sept 2017
-
$29.18 M(+0.3%)
DateAnnualQuarterly
June 2017
-
$29.09 M(+0.6%)
Mar 2017
-
$28.91 M(-0.7%)
Dec 2016
$29.12 M(-2.7%)
$29.12 M(-0.7%)
Sept 2016
-
$29.34 M(-0.7%)
June 2016
-
$29.53 M(-0.6%)
Mar 2016
-
$29.73 M(-0.7%)
Dec 2015
$29.92 M(+36.8%)
$29.92 M(-2.4%)
Sept 2015
-
$30.64 M(+33.9%)
June 2015
-
$22.88 M(-0.6%)
Mar 2015
-
$23.01 M(+5.2%)
Dec 2014
$21.88 M(-9.2%)
$21.88 M(-9.7%)
Sept 2014
-
$24.22 M(-3.1%)
June 2014
-
$24.98 M(-2.9%)
Mar 2014
-
$25.74 M(+6.8%)
Dec 2013
$24.10 M(-79.8%)
$24.10 M(-18.6%)
Sept 2013
-
$29.60 M(-11.7%)
June 2013
-
$33.52 M(-13.6%)
Mar 2013
-
$38.78 M(-67.4%)
Dec 2012
$119.13 M(+55.4%)
$119.13 M
Dec 2011
$76.66 M
-

FAQ

  • What is Epizyme annual total long term liabilities?
  • What is the all time high annual total long term liabilities for Epizyme?
  • What is Epizyme annual total long term liabilities year-on-year change?
  • What is Epizyme quarterly total long term liabilities?
  • What is the all time high quarterly long term liabilities for Epizyme?
  • What is Epizyme quarterly long term liabilities year-on-year change?

What is Epizyme annual total long term liabilities?

The current annual total long term liabilities of EPZM is $264.49 M

What is the all time high annual total long term liabilities for Epizyme?

Epizyme all-time high annual total long term liabilities is $264.49 M

What is Epizyme annual total long term liabilities year-on-year change?

Over the past year, EPZM annual total long term liabilities has changed by +$19.22 M (+7.83%)

What is Epizyme quarterly total long term liabilities?

The current quarterly long term liabilities of EPZM is $249.49 M

What is the all time high quarterly long term liabilities for Epizyme?

Epizyme all-time high quarterly total long term liabilities is $272.16 M

What is Epizyme quarterly long term liabilities year-on-year change?

Over the past year, EPZM quarterly total long term liabilities has changed by +$5.46 M (+2.24%)